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have learnt that MMP inhibitors could produce side effects and
have not yet demonstrated a major reduction in the progression
of the disease. Certain MMPs, such as MMP-13 and ADAMTS
proteases, such as ADAMTS5, have been selected as being
the most attractive targets for the treatment of OA. The main
reason(s) for choosing selective inhibition, instead of a broad
inhibition, is based on the hypothesis that by doing so a certain
number of side effects that could potentially be related to a broad
MMP inhibition can be avoided.
Another possible way to inhibit the effect of certain catabolic
factors lies in the inhibition of certain intracellular signaling path-
ways such as the protein kinase cascades. The kinases, which
constitute the most appealing targets, include p38, ERK 1/2, and
SAPK/JNK. A recent study showed that an orally active ERK 1/2
selective inhibitors could very significantly and effectively reduce
the progression of lesions in the rabbit OA model by inhibiting the
synthesis of catabolic factors, such as MMPs. Another emerging
field of research focuses on the development of molecules that
can inhibit the binding of the transcription factors at the DNA
level. The major transcription factors targeted for the inhibition of
cytokines and MMP synthesis are NF-κB and AP-1.
On the subject of cell signaling, another interesting target are the
ligands to a group of nuclear transcription factors, the peroxisome
proliferator-activated receptor gamma (PPARγ), which act as
anti-inflammatory agents. In vivo, synthetic PPARγ ligands were
found to protect against structural damages in the collagen-
induced arthritis model and in OA models.
OA structural changes also involve modifications in the mor-
phology of the surrounding bone. Subchondral bone remodeling
is a well-recognized manifestation of OA. New data underline
the concept that abnormal subchondral bone cell functions may
contribute to the onset/progression of OA. Therapeutic effects
of drugs that prevent the abnormal metabolism of subchondral
osteoblasts on the progression of OA lesions is currently of major
interest in the context of future DMOAD development.
Several new pharmacologic DMOAD agents are under inves-
tigation. Preclinical results are promising and demonstrate the
possibility of retarding or inhibiting the progression of joint tissue
structural changes. The tools to study such effects in the human
population remain unsatisfactory. Existing radiologic methods
are useful but this methodology is imperfect and time consum-
ing. Faster and more accurate methods are needed to improve
the investigation of new drugs that have the potential to modify
the progression of OA.
In conclusion, several interesting new approaches for the treat-
ment of this disease are now being explored. New classes of
molecules that inhibit one or more of the disease processes of
OA are under evaluation for their potential to alter the degenera-
tive process
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Introduction: Recent animal experiments have demonstrated
that engineered cartilage tissues generated by culturing chon-
drocytes into 3D scaffolds provide functional templates for the
orderly repair of critically sized osteochondral lesions. In order to
reproducibly generate functional cartilage tissues starting from
adult human cells, efforts have to be directed not only to the
identification of stimulatory biochemical factors, but also to the
development and use of controlled bioreactor systems, applying
defined regimes of physical forces. In this work, we present some
examples on the use of bioreactors for processes that are key for
engineering of 3D cartilage tissues based on cells and scaffolds,
namely the chondrocyte seeding into porous scaffolds, their ef-
ficient nutrition, and the pysical conditioning of the developing
tissues.
Chondrocyte seeding and culture under perfusion: In the cell
seeding process, cells must be utilized with maximum efficiency
to minimize the biopsy size needed and/or the extent of cell
expansion, and must be dispersed uniformly throughout the
scaffold volume to form the basis for uniform tissue formation.
To overcome limitations associated with the most commonly
employed seeding techniques, we developed a bioreactor for
the automated cell seeding of three-dimensional scaffolds by
continuous perfusion of a cell suspension through the scaffold
pores in oscillating directions. Perfusion seeding of chondrocytes
into Polyactive foams (IsoTis OrthoBiologics, NL) or Hyaff?-11
non-woven meshes (Fidia Advanced Biopolymers, IT) resulted
in the highest fraction of viable cells within the foam pores, the
greatest efficiency of seeding and the highest uniformity of cell
distribution in comparison to the typically used static and spinner
flask methods [1].
Constructs uniformly seeded by perfusion and then cultured
statically for 2 weeks were highly heterogeneous in structure,
consisting of a layer of cells and matrix at the periphery and an
essentially void interior region. Instead, constructs cultured under
prolonged perfusion were remarkably homogeneous, containing
a uniform distribution of both cells and matrix throughout the
cross-section [2].
Physical conditioning of cartilagel constructs: Application of
dynamic compression to cell-polymer constructs could poten-
tially improve the development of cartilaginous tissue in vitro.
We exposed human articular chondrocytes-based cartilaginous
constructs at different stages of maturation, as defined by the
glycosaminoglycan (GAG) content, to intermittent compressive
deformation for 3 days. Compression-induced changes in GAG
synthesis and accumulation were positively correlated to the
GAG content prior to loading, such that compression was stimu-
latory only for the most developed constructs. Therefore, under
our experimental conditions, cyclic loading appears to be appli-
cable for the enhancement of cartilaginous tissue development
only in the late phases of tissue regeneration [3]. Our results
also point out the possible use of bioreactors applying defined
regimes of physical forces as a quality control tool for engineered
cartilage, with the goal of defining when the tissues are suffi-
ciently developed for immediate load bearing after implantation.
Conclusion: The reviewed studies indicate that bioreactors en-
able generation of cartilaginous tissue constructs and may con-
tribute to understand the function of specific chemico-physical
culture parameters on cartilage tissue development. In the fu-
ture, bioreactors are expected to efficiently translate laboratory-
to inductrial-scale cartilage tissue engineering, possibly providing
an economically viable approach to the automated manufacture
of functional cartilage grafts for broad clinical use [4].
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Purpose: The most dominant subjective problem of the patient
suffering from osteoarthritis is pain. In most cases pain is local-
ized to the joint with OA but it can be referred to other joints.
OA pain varies in intensity and is usually worsened by exercise
